ASAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Asana Inc (ASAN) is not a strong buy for a beginner, long-term investor at this time. The stock's technical indicators, financial performance, and analyst sentiment suggest a lack of immediate upside potential. While there are some positive developments in AI-related revenue, the company's overall growth and profitability remain underwhelming. A 'hold' recommendation is appropriate given the current data.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 49.534, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 6.079, with key resistance at 6.656 and support at 5.503. Overall, the technical indicators do not signal a strong buying opportunity.
Asana's AI Studio has reached $6M in annual recurring revenue, and AI Teammates beta has launched with 200 customers. AI is expected to contribute 15% of new ARR in FY27, which could drive future growth. Additionally, some analysts note stabilization in net retention rates and gross retention trends.
The company has been downgraded by Piper Sandler to Neutral, citing challenges in growth and profitability. Other analysts have lowered price targets significantly, reflecting concerns about slower self-service growth, tech vertical softness, and disappointing FY27 guidance. The company's financial performance in Q4 2026 also shows declining net income, EPS, and gross margin.
In Q4 2026, revenue increased by 9.15% YoY to $205.57M, but net income dropped by 48.29% YoY to -$32.21M. EPS also declined by 48.15% YoY to -$0.14, and gross margin fell slightly to 87.84%. These metrics indicate weak profitability and limited growth momentum.
Analyst sentiment is mixed to negative. Piper Sandler downgraded the stock to Neutral with a price target of $7, citing challenges in growth and profitability. RBC Capital upgraded the stock to Sector Perform but kept the price target at $7, highlighting positive feedback on AI products. Other analysts have lowered price targets significantly, with concerns about slower growth and disappointing guidance.
